These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12878796)

  • 1. [The value of the proton magnetic resonance spectroscopy (HMRS) of white matter injury in children treated with chemo- and/or radiotherapy. Preliminary report].
    Jurkiewicz E; Pakuła-Kościesza I; Drogosiewicz M; Dembowska-Bagińska B; Perek D
    Med Wieku Rozwoj; 2003; 7(2):249-60. PubMed ID: 12878796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
    Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary assessment of HMRS clinical usefulness in children with partial epilepsy].
    Kaciński M; Zajac A; Kroczka S; Gergont A
    Przegl Lek; 2006; 63(11):1191-7. PubMed ID: 17348414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The experience of treatment of 7 cases of olfactory neuroblastoma].
    Zou L; Cheng Q
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Feb; 13(2):60-1. PubMed ID: 12564017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 53 cases of esthesioneuroblastoma].
    Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ
    Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton therapy for pediatric and adolescent esthesioneuroblastoma.
    Lucas JT; Ladra MM; MacDonald SM; Busse PM; Friedmann AM; Ebb DH; Marcus KJ; Tarbell NJ; Yock TI
    Pediatr Blood Cancer; 2015 Sep; 62(9):1523-8. PubMed ID: 25820437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
    Isobe T; Akutsu H; Yamamoto T; Shiigai M; Masumoto T; Nakai K; Takano S; Anno I; Matsumura A
    No Shinkei Geka; 2011 May; 39(5):485-90. PubMed ID: 21512199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esthesioneuroblastoma: continued follow-up of a single institution's experience.
    Loy AH; Reibel JF; Read PW; Thomas CY; Newman SA; Jane JA; Levine PA
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):134-8. PubMed ID: 16490869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: value of proton magnetic resonance spectroscopy.
    Kimura T; Sako K; Tohyama Y; Aizawa S; Yoshida H; Aburano T; Tanaka K; Tanaka T
    Acta Neurochir (Wien); 2003 Jul; 145(7):557-64; discussion 564. PubMed ID: 12910398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Delayed cerebral radiation necrosis.
    Tran TA; Fuller GN; Whitman GJ; Schomer DF
    AJR Am J Roentgenol; 2003 Jan; 180(1):70. PubMed ID: 12490478
    [No Abstract]   [Full Text] [Related]  

  • 19. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
    Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain injury after proton therapy or carbon ion therapy for head-and-neck cancer and skull base tumors.
    Miyawaki D; Murakami M; Demizu Y; Sasaki R; Niwa Y; Terashima K; Nishimura H; Hishikawa Y; Sugimura K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):378-84. PubMed ID: 19735866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.